Posted by Michael Wonder on 25 Nov 2020
Third major COVID-19 vaccine shown to be effective and cheaper
24 November 2020 - Drugmaker AstraZeneca said late-stage trials showed its COVID-19 vaccine is highly effective, buoying the prospects of a relatively cheap, easy-to-store product that may become the vaccine of choice for the developing world.
AstraZeneca, which has pledged it won’t make a profit on the vaccine during the pandemic, has reached agreements with governments and international health organisations that put its cost at about US$2.50 (A$3.50) a dose.
Pfizer’s vaccine costs about US$20 (A$27), while Moderna’s is US$15 (A$20) to US$25 (A$34), based on agreements the companies have struck to supply their vaccines to the US Government.
